COMMUNIQUÉS West-GlobeNewswire

DBV Technologies Highlights Poster Presentations on EPIT® at the 2017 EAACI Congress
17/06/2017
Press Release Montrouge, France, June 17, 2017 DBV Technologies Highlights Poster Presentations on EPIT ® at the 2017 EAACI Congress DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) [...]
DBV Technologies présente des données sur l'immunothérapie épicutanée (EPIT®) au Congrès de l'EAACI 2017
17/06/2017
Communiqué de Presse Montrouge, France, 17 juin 2017, 8h30 CEST DBV Technologies présente des données sur l'immunothérapie épicutanée (EPIT ® ) au Congrès de l'EAACI 2017 DBV Technologies (Euronext : DBV - ISIN : [...]
Novartis International AG: New patient survey highlights need for more action to help severe asthma patients gain control of their disease
17/06/2017
Large-scale European patient survey found that 94% of severe allergic asthma patients were unable to fully control their disease These new data underscore the disconnect between self-perceived control and clinical [...]
GENFIT : RESULTATS DE L'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 16 JUIN 2017
16/06/2017
GENFIT : resultats de l'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 16 JUIN 2017 - Approbation du changement du mode d'administration de la Société - Nomination du Président-Directeur Général et des Comités du [...]
GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 16, 2017
16/06/2017
GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 16, 2017 - Approval of the change in mode of administration and management of the Company - Nomination of the Chairman and CEO and the [...]
Diaxonhit : Assemblée générale ordinaire et extraordinaire annuelle
16/06/2017
Assemblée générale ordinaire et extraordinaire annuelle de Diaxonhit Les actionnaires ont adopté toutes les résolutions à titre ordinaire et à titre extraordinaire agréées par le directoire Paris, France - 16 juin 2017 [...]
FDA posts briefing materials prior to Advisory Committee meeting for Victoza® label update
16/06/2017
Bagsværd, Denmark, 16 June 2017 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has published the briefing documents ahead of the Advisory Committee meeting to discuss the supplemental New [...]
Kymab Group Ltd: Kymab appoints Dr Martin Nicklasson as Non-Executive Chair
16/06/2017
Kymab appoints Dr Martin Nicklasson as Non-Executive Chair Cambridge, UK, 16 June 2017 - Kymab Group Limited ("Kymab"), a leading human monoclonal antibody biopharmaceutical group, announces the appointment of Dr Martin [...]
Bavarian Nordic Announces Notification of Request for Proposal for Freeze-Dried IMVAMUNE
16/06/2017
Sole source request will allow transition toward long-term stockpiling of Bavarian Nordic's smallpox vaccine COPENHAGEN, Denmark, June 16, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced notification [...]
Helsinn Investment Fund leads the financial round in GreenBone
16/06/2017
Helsinn Investment Fund leads the financial round in GreenBone New fund backed by the Helsinn Group, focused on supporting early stage opportunities in areas of high unmet patient need Euro 2 million investment in [...]
RECORDATI LICENSES AN INNOVATIVE TREATMENT FOR NEUROTROPHIC KERATITIS
16/06/2017
Milan, 16 June, 2017 - Recordati announced the signing of an exclusive license agreement with MimeTech, an Italian development stage company founded by scientists from the University in Florence, for the development and [...]
Annual General Meeting of Active Biotech AB
16/06/2017
PRESS RELEASE The Annual General Meeting of Active Biotech was held on June 15, 2017. In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid. The board members and the [...]
Bavarian Nordic Provides Update on Anticipated Timing of PROSPECT Study
16/06/2017
COPENHAGEN, Denmark, June 16, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today provided updated guidance for the current anticipated timing of interim and final results from its ongoing PROSPECT study, a placebo [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
16/06/2017
REGULATED INFORMATION GHENT, Belgium, 16 June 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Idorsia - Reaching out for more
16/06/2017
Idorsia commences trading on SIX Swiss Exchange (ticker: IDIA) Allschwil, Switzerland - 16 June 2017 - Idorsia Ltd (SIX: IDIA) today announced its debut as an independent company newly listed on SIX Swiss Exchange. The [...]
Johnson & Johnson Completes Acquisition of Actelion
16/06/2017
ALLSCHWIL/BASEL, SWITZERLAND - 16 June 2017 - Actelion Ltd (SIX: ATLN) today announced the completion of the acquisition of Actelion Ltd by Johnson & Johnson for a total purchase price of approximately $30 billion [...]
DBV Technologies annonce la nomination de Julie O'Neill au conseil d'administration
15/06/2017
Communiqué de Presse Montrouge, France, le 15 juin 2017, 22h30 CEST DBV Technologies annonce la nomination de Julie O'Neill au conseil d'administration DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : [...]
DBV Technologies Announces Appointment of Julie O'Neill to Board of Directors
15/06/2017
Press Release Montrouge, France, June 15, 2017 DBV Technologies Announces Appointment of Julie O'Neill to Board of Directors DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) announced [...]
DBV Technologies Annonce les Résultats de son Assemblée Générale Mixte 2017
15/06/2017
Informations Réglementées Montrouge, France, le 15 juin 2017, 22h30 CEST DBV Technologies Annonce les Résultats de son Assemblée Générale Mixte 2017 Toutes les résolutions ont été adoptées L'Assemblée Générale Mixte de [...]

Pages